ReneuRx™ therapy is intended to induce a reversible inhibition of the nerve and provide pain relief that lasts exponentially longer than the current methods.
Pain, quite simply, is a pain. It can mean complicated procedures to control it, disruption of the patient’s daily life and impairment of psychological well being. Pain can hinder recovery from surgery and lead to a devastating dependence on opioids. We call this the pain of pain.
Despite being one the most fundamental of human ailments, progress in managing pain has been stagnant. After thousand of years the mainstays of pain management are still short acting anesthetics and addictive opioids.
This is about to change with Brixton’s ReneuRx™ therapy
ReneuRx™ therapy has the potential to redefine the duration of pain control. Imagine being pain free for 3 months or more with a simple injection.
Sameer Sabir, CEO, Brixton Biosciences
